U.S. Food and Drug Administration (FDA) last week approved a new drug for the Human Immunodeficiency Virus (HIV) infectious diseases. The drug made ??by a company called Tibotec Therapeutics, Johnson & Johnson Ortho Biotech Inc subsidiary. will be sold under the brand of Edurant, and was created as a combination with antiretroviral drugs.
The drug can be used by adult patients who have not received previous treatment. Edurat consumed once a day, serves to stop the replication of HIV and reduce viral levels in blood. (more…)